The FDA granted orphan drug designation to HLX22 for gastric cancer, advancing global phase 3 trials to improve first-line ...

Treatment with pimitespib was associated with stable disease in two-thirds of patients with advanced gastrointestinal stromal ...

Researchers sought to identify studies on enteral feeding and its effects on nutrition status, survival, and quality of life in patients with upper gastrointestinal cancers.

Gilead and Arcus’ efforts to rebuild confidence in TIGIT as a drug target for cancer immunotherapies ... used for previously untreated upper gastrointestinal (GI) cancers. Preliminary data ...

is one of the leading causes of cancer-related deaths worldwide. One of the most promising advancements in combating gastrointestinal cancers is the rise of precision medicine and immunotherapy ...

A team of researchers from Cleveland Clinic Genomic Medicine share insights from an early set of 19,000 patients to receive ...